CorMedix Inc.
US ˙ NasdaqGM ˙ US21900C3088

SecurityCRMD / CorMedix Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership38,151 shares
Latest Disclosed Value $ 259,045
Citigroup Inc reports 21.89% decrease in ownership of CRMD / CorMedix Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 38,151 shares of CorMedix Inc. (US:CRMD) valued at $259,045 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 48,845 shares of CorMedix Inc.. This represents a change in shares of -21.89% during the quarter. The current value of the position is $313,983 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CORMEDIX COM 21900C308 38,151 -10,694 -21.89 259 -54.40 0.0001
2026-02-13 2025-12-31 13F CORMEDIX COM 21900C308 48,845 114 0.23 568 0.35 0.0003
2025-11-10 2025-09-30 13F CORMEDIX COM 21900C308 48,731 14,921 44.13 567 36.06 0.0003
2025-08-11 2025-06-30 13F CORMEDIX COM 21900C308 33,810 -23,814 -41.33 417 17.51 0.0002
2025-05-12 2025-03-31 13F CORMEDIX COM 21900C308 57,624 -5,745 -9.07 355 -30.99 0.0002
2025-02-12 2024-12-31 13F CORMEDIX COM 21900C308 63,369 23,464 58.80 513 59.32 0.0003
2024-11-12 2024-09-30 13F CORMEDIX COM 21900C308 39,905 27,680 226.42 322 519.23 0.0002
2024-08-12 2024-06-30 13F CORMEDIX COM 21900C308 12,225 2,980 32.23 53 33.33 0.0000
2024-05-10 2024-03-31 13F CORMEDIX COM 21900C308 9,245 1,520 19.68 39 34.48 0.0000
2024-02-09 2023-12-31 13F CORMEDIX COM 21900C308 7,725 7,702 33,486.96 29 0.0000
2023-12-06 2023-09-30 13F/A-1 CORMEDIX COM 21900C308 23 -16,944 -99.86 0 -100.00 0.0000
2023-11-09 2023-09-30 13F CORMEDIX COM 21900C308 23 -16,944 0 0.0000
2023-08-10 2023-06-30 13F CORMEDIX COM 21900C308 16,967 16,967 67 0.0000
2022-11-10 2022-09-30 13F CORMEDIX COM 21900C308 0 -386 -100.00 0 -100.00
2022-08-10 2022-06-30 13F CORMEDIX COM 21900C308 386 -1,239 -76.25 2 -77.78 0.0000
2022-05-12 2022-03-31 13F CORMEDIX COM 21900C308 1,625 -8,019 -83.15 9 -79.55 0.0000
2022-02-10 2021-12-31 13F CORMEDIX COM 21900C308 9,644 5,327 123.40 44 120.00 0.0000
2021-11-10 2021-09-30 13F CORMEDIX COM 21900C308 4,317 2,515 139.57 20 66.67 0.0000
2021-08-10 2021-06-30 13F CORMEDIX COM 21900C308 1,802 -2,633 -59.37 12 -72.73 0.0000
2021-05-13 2021-03-31 13F CORMEDIX COM 21900C308 4,435 -1,408 -24.10 44 2.33 0.0000
2021-02-11 2020-12-31 13F CORMEDIX COM 21900C308 5,843 4,363 294.80 43 377.78 0.0000
2020-11-12 2020-09-30 13F CORMEDIX COM 21900C308 1,480 -2,004 -57.52 9 -59.09 0.0000
2020-08-12 2020-06-30 13F CORMEDIX COM 21900C308 3,484 -4,054 -53.78 22 -18.52 0.0000
2020-05-12 2020-03-31 13F CORMEDIX COM 21900C308 7,538 2,388 46.37 27 -27.03 0.0000
2020-02-12 2019-12-31 13F CORMEDIX COM 21900C308 5,150 3,982 340.92 37 362.50 0.0000
2019-11-08 2019-09-30 13F CORMEDIX COM 21900C308 1,168 -5,435 -82.31 8 -86.44 0.0000
2019-08-12 2019-06-30 13F CORMEDIX COM 21900C308 6,603 6,603 59 0.0000
2016-11-10 2016-09-30 13F CORMEDIX COM 21900C100 0 -48 -100.00 0 0.0000
2016-08-12 2016-06-30 13F CORMEDIX COM 21900C100 48 -29,832 -99.84 0 -100.00
2016-05-13 2016-03-31 13F CORMEDIX COM 21900C100 29,880 19,558 189.48 79 276.19 0.0001
2016-02-12 2015-12-31 13F CORMEDIX COM 21900C100 10,322 10,317 206,340.00 21 0.0000
2015-11-13 2015-09-30 13F CORMEDIX COM 21900C100 5 -398 -98.76 0 -100.00
2015-08-13 2015-06-30 13F CORMEDIX COM 21900C100 403 403 0.00 2 0.0000
2015-05-14 2015-03-31 13F CORMEDIX COM 21900C100 0 -257 -100.00 0 0.0000
2015-02-17 2014-12-31 13F CORMEDIX COM 21900C100 257 -48 -15.74 0 -100.00
2014-11-14 2014-09-30 13F CORMEDIX COM 21900C100 305 -2,495 -89.11 1 -80.00 0.0000
2014-08-14 2014-06-30 13F CORMEDIX COM 21900C100 2,800 2,774 10,669.23 5 0.0000
2014-05-15 2014-03-31 13F CORMEDIX COM 21900C100 26 26 -76.58 0 0.0000
2013-11-14 2013-09-30 13F CORMEDIX COM 21900C100 0 -111 -100.00 0 0.0000
2013-08-14 2013-06-30 13F CORMEDIX COM 21900C100 111 111 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.